Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(530) Population Pharmacokinetic Analysis of Ensitrelvir, an Inhibitor of 3C-like (3CL) Protease of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for patients with SARS-Cov-2 Infection

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • TI

    Toru Ishibashi, Ph.D (he/him/his)

    Senior Staff
    Shionogi & Co., Ltd.
    Osaka, Osaka, Japan

    • Co-Author(s)

  • LN

    Luna Nomura, B.S.

    SHIONOGI & CO., LTD.
    Osaka, Osaka, Japan

  • Ryosuke Shimizu

    Manager
    Clinical Pharmacology & Pharmacokinetics, Project Management Department, Shionogi & Co., Ltd. Osaka, Japan
    Osaka, Osaka, Japan

  • RK

    Ryuji Kubota, Ph.D.

    Clinical Pharmacology & Pharmacokinetics, Project Management Department, Shionogi & Co., Ltd. Osaka, Japan
    Osaka, Osaka, Japan